IVIEW Therapeutics Unveils Promising Outcomes in Phase 1/2 IVW-1001 Trial for Effective Dry Eye Treatment IVIEW Therapeutics highlights promising results from its Phase 1/2 trial of IVW-1001, signaling a new hope for dry eye disease sufferers.

IVIEW Therapeutics Unveils Promising Outcomes in Phase 1/2 IVW-1001 Trial for Effective Dry Eye Treatment #United_States #Cranbury #Dry_Eye_Disease #IVIEW_Therapeutics #IVW-1001